CD8A and neoplasm: Olaparib promotes CD8+ T-cell infiltration via the cGAS/STING pathway, especially in BRCA1-deficient tumours [459,460], while increased cytosolic DNA leads to CCL5/CXCL10-driven T-cell recruitment, independent of BRCA status [461].